id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
VA-2013-VHA-0005-0006,VA,VA-2013-VHA-0005,AO45 - Final Rule - Disclosures to Participate in State Prescription Drug Monitoring Programs,Rule,,2014-03-14T04:00:00Z,2014,3,,,2014-03-18T17:16:05Z,2014-05691,0,0,0900006481665bc1
VA-2013-VHA-0005-0001,VA,VA-2013-VHA-0005,AO45 - Interim Final Rule - Disclosures To Participate in State Prescription Drug Monitoring Programs,Rule,,2013-02-11T05:00:00Z,2013,2,2013-02-11T05:00:00Z,2013-04-13T03:59:59Z,2013-04-16T01:02:49Z,2013-03001,0,0,09000064811f2050
VA-2013-VHA-0005-0002,VA,VA-2013-VHA-0005,Impact Analysis on AO45-Interim Final Rule,Supporting & Related Material,,2013-02-11T05:00:00Z,2013,2,,,2013-02-11T16:30:04Z,,0,0,09000064811f14b7